Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

Essential Medicines Buffer Stock — Supply and Storage of Peritoneal Dialysis Fluids

  • First published: 26 June 2018
  • Last modified: 26 June 2018

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
Department of Health
Authority ID:
AA21010
Publication date:
26 June 2018
Deadline date:
17 July 2018
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

Peritoneal Dialysis Fluids — a full list of PD fluids and the related tender documents are published on contracts finder.

Please follow the link: https://www.contractsfinder.service.gov.uk/Search

Please sign up to the Department's tendering system via the below link to be able to register interest and complete your tender submission.

https://dh.bravosolution.co.uk/web/login.html

The Authority owns an Essential Medicines Buffer Stockpile (EMBS), which was first set up in 2009. The purpose of the EMBS is to have medicines that are routinely used in the NHS, available for release into the UK supply chain in the event of pandemic or other health emergency. The current EMBS contract was finalised in November 2015 and runs for 4 years to November 2019.

A clinical review of the current EMBS contract has identified revisions to intravenous (IV) and Peritoneal Dialysis (PD) fluids for which there are at present no contracts or buffer stocks. Creating a buffer stock for PD fluids is the subject of this procurement.

The Essential Medicines Buffer Stock for PD fluids will operate differently to other national stockpiles in that the suppliers who win the contracts are required to store and rotate the stock through their normal supply chain to prevent it from expiring. All the stock must be held with at least a 12 month expiry date and it must be held within the UK. The Contract will be for a period of up to 17 months with the option to extend a further 12 months at the Authorities discretion.

Full notice text

Contract notice

Section I: Contracting authority

I.1) Name and addresses

Department of Health and Social Care

39 Victoria Street

London

SW1H 0EU

UK

Telephone: +44 2072104850

E-mail: sam.richman@dh.gsi.gov.uk

NUTS: UK

Internet address(es)

Main address: https://www.gov.uk/government/organisations/department-of-health/about/procurement

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://dh.bravosolution.co.uk/web/login.html


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://dh.bravosolution.co.uk/web/login.html


Tenders or requests to participate must be sent to the abovementioned address


I.4) Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Essential Medicines Buffer Stock — Supply and Storage of Peritoneal Dialysis Fluids

II.1.2) Main CPV code

33690000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

In the event of a pandemic or other health emergency it is likely that medicines supply may be disrupted. Supply disruptions could put an additional burden on the health system. As part of ongoing strategic work to ensure the continuity of medicine supplies particularly during a pandemic or other emergency, the Authority owns an Essential Medicines Buffer Stockpile (EMBS), which was first set up in 2009.

A clinical review of the current EMBS contract has identified revisions to intravenous (IV) and peritoneal dialysis (PD) fluids for which there are at present no contracts or buffer stocks. Creating a buffer stock for PD fluids is the subject of this procurement.

The Authority is looking for a supplier / suppliers to be able to fulfill the products listed in the specification. The Authority will be using the Open procedure procurement route.

II.1.5) Estimated total value

Value excluding VAT: 11 000 000.00  GBP

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

Peritoneal Dialysis Fluids — a full list of PD fluids and the related tender documents are published on contracts finder.

Please follow the link: https://www.contractsfinder.service.gov.uk/Search

Please sign up to the Department's tendering system via the below link to be able to register interest and complete your tender submission.

https://dh.bravosolution.co.uk/web/login.html

The Authority owns an Essential Medicines Buffer Stockpile (EMBS), which was first set up in 2009. The purpose of the EMBS is to have medicines that are routinely used in the NHS, available for release into the UK supply chain in the event of pandemic or other health emergency. The current EMBS contract was finalised in November 2015 and runs for 4 years to November 2019.

A clinical review of the current EMBS contract has identified revisions to intravenous (IV) and Peritoneal Dialysis (PD) fluids for which there are at present no contracts or buffer stocks. Creating a buffer stock for PD fluids is the subject of this procurement.

The Essential Medicines Buffer Stock for PD fluids will operate differently to other national stockpiles in that the suppliers who win the contracts are required to store and rotate the stock through their normal supply chain to prevent it from expiring. All the stock must be held with at least a 12 month expiry date and it must be held within the UK. The Contract will be for a period of up to 17 months with the option to extend a further 12 months at the Authorities discretion.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 29

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: Yes

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

DHSC expressly reserves the rights:

i) to cancel this tendering process at any stage;

ii) not to award any framework or contract as a result of the tendering process commenced by publication of this notice; and

iii) to make whatever changes it may see fit to the content and structure of this tendering process.

In no circumstances will DHSC be liable for any costs incurred by bidders.

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents


III.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


III.2) Conditions related to the contract

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure - Accelerated procedure

Justification:

The Authority recently tendered for PD fluids and IV fluids under 2018/S 025-052743

However due to conflicting information received part way through the procurement about the product, a decision was taken to cancel the PD fluids from the tender until such time that the conflicting information was verified for accuracy. This information has now been verified and the Authority wishes to re-tender for the PD fluids on an accelerated basis to ensure that stockpile shortages are minimal. There are no changes to the tender documents in terms of product specification. Volumes are detailed within the documentation.

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2018/S 025-052743

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 17/07/2018

Local time: 15:00

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

IV.2.7) Conditions for opening of tenders

Date: 17/07/2018

Local time: 15:00

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: No

VI.2) Information about electronic workflows

Electronic ordering will be used

Electronic invoicing will be accepted

VI.3) Additional information

This procurement exercise will be conducted via the Authority's e-Tendering portal. We call this system Bravo. Applicants wishing to be considered for this procurement must register their details and download and complete the Invitation to Tender (ITT) documents and submit their response via Bravo. The following link will take you to the guidance documentation for using Bravo i.e. to register and download instructions on how to respond.

https://www.gov.uk/government/organisations/department-of-ealth/about/procurement

If you require assistance, please contact the Bravo Help-desk on 0800 069 8630 or help@bravosolution.co.uk

VI.4) Procedures for review

VI.4.1) Review body

High Court

London

WC2A 2LL

UK

VI.5) Date of dispatch of this notice

22/06/2018

Coding

Commodity categories

ID Title Parent category
33690000 Various medicinal products Pharmaceutical products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
sam.richman@dh.gsi.gov.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.